Richard D Katz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard D Katz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard D Katz. Richard D Katz is a Ex VP, Fin & Corp, CFO & Treas in ICAGEN INC ($ICGN) and a Sr VP, Fin & Corp, CFO & Treas in ICAGEN INC ($ICGN) and a Vice President and CFO in ARGOS THERAPEUTICS INC ($ARGS) and a VP & Chief Financial Officer in ARGOS THERAPEUTICS INC ($ARGS) and a VP and Chief Financial Officer in ARGOS THERAPEUTICS INC ($ARGS) and a Chief Financial Officer in Liquidia Technologies Inc ($LQDA).
Address: C/O ICAGEN, INC., 4222 EMPEROR BOULEVARD SUITE 350 DURHAM 27703 NC
Companies in which Richard D Katz is an Insider
ARGOS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard D Katz: Vice President and CFO, VP and Chief Financial Officer, VP & Chief Financial Officer
Holdings: 9,697 shares
Current Value: $47,030
Latest Transaction: Apr 25 2018
$ARGS Market Capitalization: $208.29M
$ARGS Previous Close: $4.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ICAGEN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard D Katz: Ex VP, Fin & Corp, CFO & Treas, Sr VP, Fin & Corp, CFO & Treas
Holdings: 0 shares
Latest Transaction: Sep 27 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Liquidia Technologies Inc
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Richard D Katz: Chief Financial Officer
Holdings: 10,833 shares
Latest Transaction: Mar 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard D Katz
Sentiment: All, ARGS, ICGN, LIQDA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2020 | LIQDA | Liquidia Technolog ... | Katz Richard D | Chief Financial Off ... | Option Exercise | A | 3.31 | 43,333 | 143,432 | 43,333 | |
| Mar 20 2020 | LIQDA | Liquidia Technolog ... | Katz Richard D | Chief Financial Off ... | Grant | A | 0.00 | 10,833 | 0 | 10,833 | 0 to 10.8 K |
| May 22 2019 | LQDA | Liquidia Technolog ... | Katz Richard D | Chief Financial Off ... | Option Exercise | A | 10.29 | 155,000 | 1,594,950 | 155,000 | |
| May 22 2019 | LQDA | Liquidia Technolog ... | Katz Richard D | Chief Financial Off ... | Option Exercise | A | 10.29 | 155,000 | 1,594,950 | 155,000 | |
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | D | 0.00 | 22,629 | 0 | 9,697 | 32.3 K to 9.7 K (-70.00 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |